HTL Strefa

MTD Group takes part in the global effort to accelerate the COVID-19 vaccination, thanks to its new Low Dead Space syringes.

In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of individuals that can benefit from the available vaccine vials.

The MTD Group, leveraging its Research Hub located in Como (Italy), with its decades of experience in designing and producing needles and syringes, has made investments to take part in the global effort to supply products that will minimize vaccine waste, and help to accelerate the COVID-19 vaccination effort according to the above recommendations.

For more information see the full communication: